Asston Pharmaceuticals Ltd. IPO

Asston Pharmaceuticals Ltd. is listed in the SME segment. The figures below are as reported by the exchanges and public sources.

Asston Pharmaceuticals Ltd. IPO — key facts

• As of 6 September 2026, the Asston Pharmaceuticals Ltd. IPO subscription status is 186.55x overall.
• The issue is open from 09-Jul-2025 to 11-Jul-2025.
• Asston Pharmaceuticals Ltd. listed on 16-Jul-2025.
• Asston Pharmaceuticals Ltd. listed at ₹124.95. The listing gain was 1.6% against the upper end of the issue price band.

Asston Pharmaceuticals Ltd. IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price

₹123

Issue size

₹27.56 Cr

Fresh issue

₹26.17 Cr

Opens

09-Jul-2025

Closes

11-Jul-2025

Listing

16-Jul-2025

Total subscription

186.55x

Retail

172.06x

QIB

85.76x

NII

353.14x

Lead managers

Sobhagya Capital

Listing price

₹124.95

Listing day change

+1.6%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.